CARA
Price
$4.78
Change
+$0.18 (+3.91%)
Updated
Jan 22 closing price
Capitalization
21.85M
34 days until earnings call
CKPT
Price
$2.77
Change
-$0.23 (-7.67%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
146.5M
Ad is loading...

CARA vs CKPT

Header iconCARA vs CKPT Comparison
Open Charts CARA vs CKPTBanner chart's image
Cara Therapeutics
Price$4.78
Change+$0.18 (+3.91%)
Volume$33K
Capitalization21.85M
Checkpoint Therapeutics
Price$2.77
Change-$0.23 (-7.67%)
Volume$29.55K
Capitalization146.5M
CARA vs CKPT Comparison Chart
Loading...
CARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARA vs. CKPT commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARA is a StrongBuy and CKPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (CARA: $4.78 vs. CKPT: $2.77)
Brand notoriety: CARA and CKPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARA: 19% vs. CKPT: 109%
Market capitalization -- CARA: $21.85M vs. CKPT: $146.5M
CARA [@Biotechnology] is valued at $21.85M. CKPT’s [@Biotechnology] market capitalization is $146.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARA’s FA Score shows that 0 FA rating(s) are green whileCKPT’s FA Score has 0 green FA rating(s).

  • CARA’s FA Score: 0 green, 5 red.
  • CKPT’s FA Score: 0 green, 5 red.
According to our system of comparison, CARA is a better buy in the long-term than CKPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARA’s TA Score shows that 1 TA indicator(s) are bullish while CKPT’s TA Score has 2 bullish TA indicator(s).

  • CARA’s TA Score: 1 bullish, 4 bearish.
  • CKPT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CKPT is a better buy in the short-term than CARA.

Price Growth

CARA (@Biotechnology) experienced а +7.17% price change this week, while CKPT (@Biotechnology) price change was -16.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

CARA is expected to report earnings on Feb 26, 2025.

CKPT is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CKPT($146M) has a higher market cap than CARA($21.9M). CKPT YTD gains are higher at: -13.438 vs. CARA (-21.895). CKPT has higher annual earnings (EBITDA): -37.51M vs. CARA (-88.8M). CKPT has less debt than CARA: CKPT (2.47M) vs CARA (3.42M). CARA has higher revenues than CKPT: CARA (8.69M) vs CKPT (47K).
CARACKPTCARA / CKPT
Capitalization21.9M146M15%
EBITDA-88.8M-37.51M237%
Gain YTD-21.895-13.438163%
P/E RatioN/AN/A-
Revenue8.69M47K18,481%
Total CashN/A4.7M-
Total Debt3.42M2.47M138%
FUNDAMENTALS RATINGS
CARA vs CKPT: Fundamental Ratings
CARA
CKPT
OUTLOOK RATING
1..100
3251
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4957
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CARA's Valuation (85) in the Biotechnology industry is in the same range as CKPT (89) in the Pharmaceuticals Major industry. This means that CARA’s stock grew similarly to CKPT’s over the last 12 months.

CARA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CKPT (100) in the Pharmaceuticals Major industry. This means that CARA’s stock grew similarly to CKPT’s over the last 12 months.

CARA's SMR Rating (99) in the Biotechnology industry is in the same range as CKPT (100) in the Pharmaceuticals Major industry. This means that CARA’s stock grew similarly to CKPT’s over the last 12 months.

CARA's Price Growth Rating (49) in the Biotechnology industry is in the same range as CKPT (57) in the Pharmaceuticals Major industry. This means that CARA’s stock grew similarly to CKPT’s over the last 12 months.

CARA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CKPT (100) in the Pharmaceuticals Major industry. This means that CARA’s stock grew similarly to CKPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CARACKPT
RSI
ODDS (%)
Bearish Trend 16 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
82%
Bullish Trend 16 days ago
90%
Momentum
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
81%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
84%
Bullish Trend 16 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
75%
Bearish Trend 16 days ago
85%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRAW5.720.21
+3.81%
Traws Pharma Inc
HUBB456.866.48
+1.44%
Hubbell
NECB25.20-0.29
-1.14%
NorthEast Community Bancorp
HHH75.00-1.33
-1.74%
Howard Hughes Holdings
BHLB28.20-0.52
-1.81%
Berkshire Hills Bancorp

CARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARA has been loosely correlated with CYCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CARA jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARA
1D Price
Change %
CARA100%
+3.91%
CYCC - CARA
61%
Loosely correlated
-1.89%
CKPT - CARA
47%
Loosely correlated
-7.67%
GPCR - CARA
41%
Loosely correlated
-1.41%
AXON - CARA
37%
Loosely correlated
+0.33%
FBIO - CARA
32%
Poorly correlated
-2.69%
More

CKPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CKPT
1D Price
Change %
CKPT100%
-7.67%
CYCC - CKPT
52%
Loosely correlated
-1.89%
GPCR - CKPT
43%
Loosely correlated
-1.41%
CYTK - CKPT
42%
Loosely correlated
+2.18%
CARA - CKPT
40%
Loosely correlated
+3.91%
AXON - CKPT
37%
Loosely correlated
+0.33%
More